Advertisement

Topics

Breast Cancer Reports

07:49 EST 12th December 2018 | BioPortfolio

Global Cancer mTOR Inhibitors Market Status and Outlook 20182025 [Report Updated: 18082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Oxford Biodynamics Plc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17092018] Prices from USD $250

SummaryOxford Biodynamics Plc Oxford Biodynamics is a developer of biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neurodegenerative conditions. Its biomarker discovery platform is used for the detection of aberrant gene ...

Sanford Health Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummarySanford Health Sanford is a healthcare service provider that offers medical services. The center provides medical services in the areas of allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding disorders, botox cosmetic, breast cancer risk consultation, 3D mammography, breast radiology, cancer ris...

RAC Alpha Serine/Threonine Protein Kinase Protein kinase B or Protein kinase B Alpha or Proto Oncogene c Akt or RAC PK Alpha or AKT1 or EC 2.7.11.1 Pipeline Review, H2 2018 [Report Updated: 13112018] Prices from USD $3500

RAC Alpha Serine/Threonine Protein Kinase Protein kinase B or Protein kinase B Alpha or Proto Oncogene c Akt or RAC PK Alpha or AKT1 or EC 2.7.11.1 Pipeline Review, H2 2018SummaryAccording to the recently published report 'RAC Alpha SerineThreonine Protein Kinase Pipeline Review, H2 2018'; RAC Alpha Serine/Threonine Protein Kinase Protein kinase B or Protein kinase B Alpha or Proto Oncogene c Ak...

Cyclin Dependent Kinase 4 Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22 Pipeline Review, H2 2018 [Report Updated: 13112018] Prices from USD $3500

Cyclin Dependent Kinase 4 Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22 Pipeline Review, H2 2018SummaryCyclin Dependent Kinase 4 Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22 Cyclindependent kinase 4 is an enzyme encoded by the CDK4 gene. Ser/Thrkinase component of cyclin DCDK4 DC complexes phosphorylate and inhibit members of the retinoblastoma RB protein f...

RAC Beta Serine/Threonine Protein Kinase Protein Kinase Akt 2 or Protein Kinase B Beta or RAC PK Beta or AKT2 or EC 2.7.11.1 Pipeline Review, H2 2018 [Report Updated: 13112018] Prices from USD $3500

RAC Beta Serine/Threonine Protein Kinase Protein Kinase Akt 2 or Protein Kinase B Beta or RAC PK Beta or AKT2 or EC 2.7.11.1 Pipeline Review, H2 2018SummaryRAC Beta Serine/Threonine Protein Kinase Protein Kinase Akt 2 or Protein Kinase B Beta or RAC PK Beta or AKT2 or EC 2.7.11.1 pipeline Target constitutes close to 9 molecules. The latest report RAC Beta SerineThreonine Protein Kinase Pipeline ...

Serine/Threonine Protein Kinase PLK1 Polo Like Kinase 1 or Serine/Threonine Protein Kinase 13 or PLK1 or EC 2.7.11.21 Pipeline Review, H2 2018 [Report Updated: 13112018] Prices from USD $3500

Serine/Threonine Protein Kinase PLK1 Polo Like Kinase 1 or Serine/Threonine Protein Kinase 13 or PLK1 or EC 2.7.11.21 Pipeline Review, H2 2018SummaryAccording to the recently published report 'SerineThreonine Protein Kinase PLK1 Pipeline Review, H2 2018'; Serine/Threonine Protein Kinase PLK1 Polo Like Kinase 1 or Serine/Threonine Protein Kinase 13 or PLK1 or EC 2.7.11.21 pipeline Target constitu...

Toll Like Receptor 8 CD288 or TLR8 Pipeline Review, H2 2018 [Report Updated: 13112018] Prices from USD $3500

Toll Like Receptor 8 CD288 or TLR8 Pipeline Review, H2 2018SummaryToll Like Receptor 8 CD288 or TLR8 Tolllike receptor 8 is a protein encoded by the TLR8 gene. It control host immune response against pathogens through recognition of molecular patterns specific to microorganisms. Acts via MYD88 and TRAF6, leading to NFkappaB activation, cytokine secretion and the inflammatory response. Toll Like ...

Fibroblast Growth Factor Receptor 4 CD334 or FGFR4 or EC 2.7.10.1 Pipeline Review, H2 2018 [Report Updated: 13112018] Prices from USD $3500

Fibroblast Growth Factor Receptor 4 CD334 or FGFR4 or EC 2.7.10.1 Pipeline Review, H2 2018SummaryFibroblast Growth Factor Receptor 4 CD334 or FGFR4 or EC 2.7.10.1 Fibroblast growth factor receptor 4 is a protein encoded by the FGFR4 gene. It plays a role in the regulation of cell proliferation, differentiation and migration, and in regulation of lipid metabolism, bile acid biosynthesis, glucose ...

Puma Biotechnology Inc PBYI Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryPuma Biotechnology Inc Puma is a biopharmaceutical company that develops novel therapeutics for the treatment of cancer. The company develops and commercializes three drug candidates, namely, PB272 neratinib, oral, PB272 neratinib, intravenous and PB357. Its pipeline portfolio also encompasses investigational candidates for various indications such as adjuvant breast cancer, gastric cancer,...

CASI Pharmaceuticals Inc CASI Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryCASI Pharmaceuticals Inc CASI is a biopharmaceutical company, which focuses on the acquisition, development and commercialization of innovative therapies for treating cancer and other unmet medical needs. Its pipeline product portfolio includes ENMD2076 that is being developed globally for the treatment of various cancers including triplenegative breast cancer, softtissue sarcoma, ovarian c...

Toll Like Receptor 3 CD283 or TLR3 Pipeline Review, H2 2018 [Report Updated: 13112018] Prices from USD $3500

Toll Like Receptor 3 CD283 or TLR3 Pipeline Review, H2 2018SummaryToll Like Receptor 3 CD283 or TLR3 pipeline Target constitutes close to 10 molecules. Out of which approximately 8 molecules are developed by companies and remaining by the universities/institutes. The latest report Toll Like Receptor 3 Pipeline Review, H2 2018, outlays comprehensive information on the Toll Like Receptor 3 CD283 o...

RAF Proto Oncogene Serine/Threonine Protein Kinase Proto Oncogene c RAF or RAF1 or EC 2.7.11.1 Pipeline Review, H2 2018 [Report Updated: 21082018] Prices from USD $3500

RAF Proto Oncogene Serine/Threonine Protein Kinase Proto Oncogene c RAF or RAF1 or EC 2.7.11.1 Pipeline Review, H2 2018SummaryRAF Proto Oncogene Serine/Threonine Protein Kinase Proto Oncogene c RAF or RAF1 or EC 2.7.11.1 RAF protooncogene serine/threonineprotein kinase or protooncogene cRAF is an enzyme is encoded by the RAF1 gene. Once activated the cellular RAF1 protein can phosphorylate to ac...

NovoCure Ltd NVCR Product Pipeline Analysis, 2018 Update [Report Updated: 16082018] Prices from USD $750

SummaryNovoCure Ltd NovoCure is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company's pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer and small cell lung cancer, among others. It also offers provides products for other indications such as ...

Sunshine Biopharma Inc SBFM Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummarySunshine BioPharma Inc Sunshine BioPharma, a subsidiary of Advanomics Corp is a pharmaceutical company that offers research, development and commercialization of drugs for treating cancer disease. The company provides generic and proprietary drugs for the treatment of cancer and other acute and chronic indications. It offers drug candidate such as Adva27a, a small molecule against different...

OBI Pharma Inc 4174 Medical Equipment Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryOBI Pharma Inc OBI Pharma is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company's products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI833, a cancer vaccine for epithelial cancers other than breast and ovarian cancer. It also develops active immu...

NovoCure Ltd NVCR Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryNovoCure Ltd NovoCure is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company's pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer and small cell lung cancer, among others. It also offers provides products for other indications such as ...

Indoleamine 2,3 Dioxygenase 1 Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52 Pipeline Review, H2 2018 [Report Updated: 16102018] Prices from USD $3500

Indoleamine 2,3 Dioxygenase 1 Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52 Pipeline Review, H2 2018SummaryIndoleamine 2,3 Dioxygenase 1 Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52 pipeline Target constitutes close to 39 molecules. Out of which approximately 35 molecules are developed by companies and remaining by the universities/institutes. The latest report ...

Histone Deacetylase 2 Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98 Pipeline Review, H2 2018 [Report Updated: 18092018] Prices from USD $3500

Histone Deacetylase 2 Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98 Pipeline Review, H2 2018SummaryHistone Deacetylase 2 Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98 pipeline Target constitutes close to 27 molecules. Out of which approximately 24 molecules are developed by companies and remaining by the unive...

Imugene Ltd IMU Financial and Strategic SWOT Analysis Review [Report Updated: 10102018] Prices from USD $125

Imugene Ltd IMU Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your busin...

Barbara Ann Karmanos Cancer Institute Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryBarbara Ann Karmanos Cancer Institute Karmanos, a subsidiary of McLaren Health Care Corp is a healthcare institute that provides patient care and educational services. The institute offers patient care for the prevention, early detection, treatment and eventual eradication of cancer. Its cancer care programs comprise treatment options and side effects, clinical trials, radiology services, w...

Basal Cell Carcinoma Basal Cell Epithelioma Pipeline Review, H2 2018 [Report Updated: 16102018] Prices from USD $2000

Basal Cell Carcinoma Basal Cell Epithelioma Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Basal Cell Carcinoma Basal Cell Epithelioma Pipeline Review, H2 2018, provides an overview of the Basal Cell Carcinoma Basal Cell Epithelioma Oncology pipeline landscape.Basal cell carcinoma is a type of skin cancer which begins in the bas...

Memorial Sloan Kettering Cancer Center Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24092018] Prices from USD $250

SummaryMemorial Sloan Kettering Cancer Center MSKCC is a healthcare service provider that offers cancer treatment, cancer research and cancer education programs. The center conducts research in therapeutic areas of bone and marrow stem cell transplantation, cancer pathology, cancer therapeutics and drug development, cell biology, cell cycle regulation, cell death, cell signaling, immunology, genet...

Interleukin 2 Receptor Subunit Alpha TAC Antigen or p55 or CD25 or IL2RA Pipeline Review, H2 2018 [Report Updated: 16102018] Prices from USD $3500

Interleukin 2 Receptor Subunit Alpha TAC Antigen or p55 or CD25 or IL2RA Pipeline Review, H2 2018SummaryAccording to the recently published report 'Interleukin 2 Receptor Subunit Alpha Pipeline Review, H2 2018'; Interleukin 2 Receptor Subunit Alpha TAC Antigen or p55 or CD25 or IL2RA pipeline Target constitutes close to 12 molecules. Interleukin 2 Receptor Subunit Alpha TAC Antigen or p55 or CD2...

Fred Hutchinson Cancer Research Center Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryFred Hutchinson Cancer Research Center Fred Hutchinson, a subsidiary of National Comprehensive Cancer Network, is a nonprofit organization which conducts research on the prevention, diagnose and treatment of cancer, HIV/AIDS and other life threatening diseases. It conducts research on various diseases such as cervical cancer, colorectal cancer, crohn's disease, cystic fibrosis, esophageal c...

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Breast Cancer market research data and corporate reports here